The European Medicines Agency's strategies to meet the challenges of Alzheimer disease

被引：0
|
作者：
Manuel Haas
Valentina Mantua
Marion Haberkamp
Luca Pani
Maria Isaac
Florence Butlen-Ducuing
Spiros Vamvakas
Karl Broich
机构：
[1] European Medicines Agency,
[2] Agenzia Italiana del Farmaco,undefined
[3] Bundesinstitut für Arzneimittel und Medizinprodukte,undefined
来源：
Nature Reviews Drug Discovery | 2015年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Regulatory agencies have a key role in facilitating the development of new drugs for Alzheimer disease, particularly given the challenges associated with early intervention. Here, we summarize the strategies of the European Medicines Agency to help address such challenges.
引用
收藏
页码：221 / 222
页数：1
相关论文
共 50 条
  • [1] The European Medicines Agency's strategies to meet the challenges of Alzheimer disease
    Haas, Manuel
    Mantua, Valentina
    Haberkamp, Marion
    Pani, Luca
    Isaac, Maria
    Butlen-Ducuing, Florence
    Vamvakas, Spiros
    Broich, Karl
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (04) : 221 - 222
  • [2] The European Medicines Agency rejects the authorization of aducanumab for Alzheimer's disease
    Dal-Re, Rafael
    [J]. REVISTA DE NEUROLOGIA, 2022, 74 (06) : 207 - 208
  • [3] THE EUROPEAN MEDICINES AGENCY'S STRATEGIES TO TACKLE THE CHALLENGES OF AD DRUG DEVELOPMENT
    Mantua, Valentina
    [J]. NEUROBIOLOGY OF AGING, 2016, 39 : S6 - S6
  • [4] For the European Medicines Agency, a decade of challenges
    Rice, M
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (19) : 1403 - 1405
  • [5] European Medicines Agency
    Camarero, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S38 - S39
  • [6] Comparing online campaigning strategies to host the European Medicines Agency
    Tunon-Navarro, Jorge
    Catalan-Matamoros, Daniel
    [J]. PROFESIONAL DE LA INFORMACION, 2020, 29 (02):
  • [7] Should the European Medicines Agency consider ageing a disease?
    Penella, Guillermo Marin
    [J]. BIOETHICS, 2024, 38 (05) : 431 - 437
  • [8] THE EUROPEAN MEDICINES AGENCY: A PUBLIC HEALTH EUROPEAN AGENCY?
    Mahalatchimy, Aurelie
    Rial-Sebbag, Emmanuelle
    De Grove-Valdeyron, Nathalie
    Tournay, Virginie
    Cambon-Thomsen, Anne
    Duguet, Anne-Marie
    Taboulet, Florence
    [J]. MEDICINE AND LAW, 2012, 31 (01): : 25 - 42
  • [9] Challenges for participatory research strategies and approaches in Alzheimer's disease
    Naue, Ursula
    Kroll, Thilo
    [J]. DISABILITY AND HEALTH JOURNAL, 2009, 2 (01) : E4 - E4
  • [10] Maintenance of mitochondrial homeostasis for Alzheimer's disease: Strategies and challenges
    Han, Ying
    Liu, Daozhou
    Cheng, Ying
    Ji, Qifeng
    Liu, Miao
    Zhang, Bangle
    Zhou, Siyuan
    [J]. REDOX BIOLOGY, 2023, 63
12345